Back
Akero Therapeutics Stock Price Chart

This color-coded "trading stoplight" keeps you in the right lane
CLICK TO WATCH
Buy
59
AKRO
Akero Therapeutics
Last Price:
46.64
Seasonality Move:
18.98%
7 Day Trial
ALL ACCESS PASS
$
7

"An AI that can make you rich?"
Click here now to see how- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.66 | Buy |
20-day SMA: | 45.7 | Buy |
50-day SMA: | 42.72 | Buy |
200-day SMA: | 39.68 | Buy |
8-day EMA: | 45.2 | Buy |
20-day EMA: | 45.01 | Buy |
50-day EMA: | 44.08 | Buy |
200-day EMA: | 38.61 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 58.79 | Buy |
Chaikin Money Flow: | 386526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.21 - 46.79) | Buy |
Bollinger Bands (100): | (40.39 - 47.63) | Buy |
Akero Therapeutics Technical Analysis
May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 46.73 while AKRO 8-day simple moving average is 44.66, which is a Buy signal.
- The stock price of AKRO is 46.73 while Akero Therapeutics 20-day SMA is 45.70, which makes it a Buy.
- Akero Therapeutics 50-day simple moving average is 42.72 while AKRO share price is 46.73, making it a Buy technically.
- AKRO stock price is 46.73 and Akero Therapeutics 200-day simple moving average is 39.68, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $46.73. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
2.59B
Price in USD:
46.73
Share Volume:
527.59K
Akero Therapeutics 52-Week Range
52-Week High:
54.88
52-Week Low:
7.52
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 46.73 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 46.73 while AKRO 8-day exponential moving average is 45.20, which is a Buy signal.
- The stock price of AKRO is 46.73 while Akero Therapeutics 20-day EMA is 45.01, which makes it a Buy.
- Akero Therapeutics 50-day exponential moving average is 44.08 while AKRO share price is 46.73, making it a Buy technically.
- AKRO stock price is 46.73 and Akero Therapeutics 200-day simple moving average is 38.61, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.76 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 58.79, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (44.21 - 46.79), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (40.39 - 47.63), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.